Dimer targeting peptide mediated precise and controllable drug delivery by upconversion nanocarriers for breast cancer therapy

Kunyu Zhang,Zhong Wan,Huabo Jiang,Xiufeng Xiao,Qian Feng,Yanchun Meng,Yongsheng Yu
DOI: https://doi.org/10.1016/j.matdes.2021.109597
2021-05-01
Abstract:<p>Breast cancer is one of the leading causes of cancer-related deaths in women. Chemotherapy remains one of the main clinical treatments for breast cancer. However, this therapy has appreciable side effects. Nanoscale carriers, such as metal nanoparticles and liposomes, are being widely utilized as drug delivery vehicles to achieve precise targeting of tumor cells. In this study, we designed a novel upconversion nanocarriers (UCNCs) host-guest complexation system based on a photolabile capping-like molecule. UCNCs containing epirubicin (EPI) were grafted with a dimer-targeting peptide <em>via</em> cyclodextrin-adamantine host-guest complexation. After entering breast tumor cells with the guidance of the dimer-targeting peptide, the core of the UCNCs upconverted near-infrared light to ultraviolet light which subsequently triggered the intracellular on-demand release of epirubicin. The precise and efficient delivery and release of epirubicin inside breast cancer cells significantly inhibited cancer cells proliferation, migration, and invasion <em>in vitro</em> and decreased the tumor size <em>in vivo</em>. We believe that this UCNCs system is a promising platform for the precise and controllable delivery of various chemotherapy drugs for clinical cancer treatments.</p>
materials science, multidisciplinary
What problem does this paper attempt to address?